Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.
Among more than 12,500 people who completed surveys after each shot, 79.4% of people reported local reactions (including itching, pain, or redness at the injection site), while 74.1% reported systemic reactions (mostly fatigue, muscle aches, and headaches), typically the day after the shot.Sep 28, 2021
Look for emergency warning signs* for COVID-19. If someone is showing any of these signs, seek emergency medical care immediately: Trouble breathing Persistent pain or pressure in the chest New confusion Inability to wake or stay awake Bluish lips or face
Regeneron's treatment, called REGEN-COV, is a combination of two types of monoclonal antibodies. Monoclonal antibodies work by targeting the coronavirus spike protein, blocking the virus from entering your body's cells, and stopping the infection from spreading.Sep 4, 2021
Fatigue, post-exercise malaise and cognitive dysfunction (or brain fog) are the most common symptoms reported by COVID long haulers 6 months after contracting the coronavirus, according to a new preprint study published on MedRxiv.Jan 5, 2021
People eligible for Pfizer's booster include those 65 and older and those who live in long-term care facilities, have underlying medical conditions or are at higher risk of exposure to the virus because of their jobs or institutional settings, a group that includes health care workers, teachers and prisoners.6 days ago
Yes. During the recovery process, people with COVID-19 might experience recurring symptoms alternating with periods of feeling better. Varying degrees of fever, fatigue and breathing problems can occur, on and off, for days or even weeks.Feb 24, 2021
Millions of vaccinated people have experienced side effects, including swelling, redness, and pain at the injection site. Fever, headache, tiredness, muscle pain, chills, and nausea are also commonly reported . As is the case with any vaccine, however, not everyone will react in the same way.Sep 21, 2021
The F.D.A. authorized emergency use of the Pfizer-BioNTech vaccine for 12- to 15-year-olds in May. Since then, more than 8.2 million children in that age group have received at least one dose, and more than 6.7 million have been fully vaccinated.5 days ago
On Dec. 11, 2020, FDA issued the first Emergency Use Authorization (EUA) for use of the Pfizer-BioNTech COVID-19 Vaccine in people aged 16 years and older, and on Dec. 13, 2020, ACIP issued recommendations for use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19.